Yu F, Huo H, Tang Q. Inhibition of proteinase-activated receptor 2 (PAR2) decreased the malignant progression of lung cancer cells and increased the sensitivity to chemotherapy. Cancer Chemother Pharmacol 2024 Jan 4. doi: 10.1007/s00280-023-04630.
PMID: 38172304